During the past decade, Wayne Radiation Oncology conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 36 clinical trials were completed, i.e. on average, 276.9% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 15 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wayne Radiation Oncology" #1 sponsor was "National Cancer Institute (NCI)" with 21 trials, followed by "Radiation Therapy Oncology Group" with 19 trials sponsored, "SWOG Cancer Research Network" with 18 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wayne Radiation Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 50 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "Eastern Cooperative Oncology Group" with 2 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Wayne Radiation Oncology" are "Head and Neck Cancer" (6 trials), "Lung Cancer" (5 trials), "Lymphoma" (5 trials), "Prostate Cancer" (5 trials) and "Recurrent Squamous Cell Lung Carcinoma" (4 trials). Many other conditions were trialed in "Wayne Radiation Oncology" in a lesser frequency.

Most popular intervention types in "Wayne Radiation Oncology" are "Drug" (60 trials), "Other" (28 trials), "Radiation" (23 trials), "Biological" (20 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (20 trials), "Quality-of-Life Assessment" (11 trials), "radiation therapy" (10 trials), "cetuximab" (6 trials) and "cisplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "Wayne Radiation Oncology" are 55 trials for "All" genders, 12 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Wayne Radiation Oncology". undefined are not yet recruiting, undefined are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Wayne Radiation Oncology, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Wayne Radiation Oncology, 1 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".